CandorVision® Wins the 2026 D.W. Bole Award for Growth, Service and Operational Excellence
Montreal, October 15th, 2026 — McKesson, Canada’s largest pharmaceutical distributor, recognizes companies at its Annual Distinction Awards Gala for excellence in manufacturing and collaboration, which result in improving the health of millions of Canadians.
David Wesley Bole was a Canadian pharmacist and businessman. He helped found the wholesaler company National Drug and Chemical Company of Canada (now McKesson Canada) in 1905 and was its first president.
The D.W. Bole Award recognizes distinction in growth, service and operational excellence.
CandorVision®, a Canadian-owned and operated company dedicated to providing the highest-quality of preservative-free dry eye and lid hygiene treatments, is proud to announce that it has won the 2026 D.W. Bole Award.
“This award recognizes our team’s dedication to operational excellence & Gold-Standard quality and service.” says Dr. Frank Heidemann, President & CEO and founder of CandorVision®. “We thank McKesson Canada for this prestigious award and look forward to continue expanding this collaboration that helps bring our eye care treatments to Canadians from coast to coast.”
We are grateful that McKesson Canada’s strong national distribution network helps to make CandorVision®’s Gold Standard dry eye treatments, such as HYLO®, Canadian ophthalmologists’ #1 choice* for long-lasting dry eye relief, widely accessible to pharmacies and patients across Canada.
Learn more about CandorVision® and HYLO® at candorvision.com.
About CandorVision®
CandorVision® is a Canadian-owned and operated company focusing on improving the level of eye healthcare through innovation and exceptional service. CandorVision® markets and distributes the highest-quality ophthalmic treatments, including the German-made HYLO® family of preservative-free and phosphate-free lubricating eye drops, OCUNOX® eye ointment, CALMO® Eye Spray, and soap-free lid hygiene solutions CALMO® Lid Care, and NACLINO® Lid Wipes.
*Based on a 2025 survey of Canadian ophthalmologists administered by an independent third party. Data on file.
About McKesson Canada
McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson Canada partners with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.
